For Time-efficient and Cost-effective Production, at the Required Purity
Molecules reaching the market in recent years present an ever-growing complexity. In the meantime, purity criteria are more important than ever to ensure patient safety. Aline Devoille at Novasep looks into how the combination of these two facts represents a big challenge for the manufacturing industry, where the right combination of state-of-the-art synthesis and advanced purification is necessary to meet the demand in a cost-effective and time-efficient manner.
(Due to an error in printing, this article is a re-run from the previous issue of IPI. – Volume 5 Issue 2)